Analysis of pediatric outpatient visits uncovers disparities in molluscum contagiosum treatment across medical specialties in the United States
https://doi.org/10.4081/dr.2023.9851
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Molluscum contagiosum (MC) is a common viral infection that affects the skin of children. This study compared demographic data and treatment patterns for MC patients across US medical specialties. Using the National Ambulatory Medical Care Survey database from 2000 to 2016, we found an average of 471,383 pediatric MC visits yearly. Most visits were made by Caucasians (91.0%) or non-Hispanics (82.9%). Pediatricians handled most cases (46.5%), followed by dermatologists (36.8%) and family medicine physicians (10.6%). Dermatologists saw more Caucasian patients (95% vs. 84%) and more patients with private insurance (83% vs. 73%) than pediatricians. Patients living in non-metropolitan areas were more likely to visit family medicine physicians (55.0%) than pediatricians (26.4%) or dermatologists (16.3%). Pediatricians favored spontaneous resolution (70%) over dermatologists (38%). Pediatricians mainly used terpenoids (12%), steroids (4%), and imiquimod (4%), while dermatologists preferred terpenoids (20%), imiquimod (12%), and curettage (10%). Pediatricians oversee most MC cases, but treatment strategies significantly differ from the best-practice guidelines.
Chen X, Anstey AV, Bugert JJ. Molluscum contagiosum virus infection. Lancet Infect Dis. 2013; 13:877-88. DOI: https://doi.org/10.1016/S1473-3099(13)70109-9
Olsen JR, Gallacher J, Piguet V, Francis NA. Epidemiology of molluscum contagiosum in children: a systematic review. Fam Pract. 2014; 31:130-6. DOI: https://doi.org/10.1093/fampra/cmt075
Tyring SK. Molluscum contagiosum: the importance of early diagnosis and treatment. Am J Obstet Gynecol. 2003; 189:S12-6. DOI: https://doi.org/10.1067/S0002-9378(03)00793-2
Basdag H, Rainer BM, Cohen BA. Molluscum contagiosum: to treat or not to treat? Experience with 170 children in an outpatient clinic setting in the northeastern United States. Pediatr Dermatol. 2015; 32:353-7. DOI: https://doi.org/10.1111/pde.12504
Lee R, Schwartz RA. Pediatric molluscum contagiosum: reflections on the last challenging poxvirus infection, Part 1. Cutis. 2010; 86:230-6.
Eichenfield L, Hebert A, Mancini A, Rosen T, Weiss J. Therapeutic Approaches and Special Considerations for Treating Molluscum Contagiosum. J Drugs Dermatol. 2021; 20:1185-90. DOI: https://doi.org/10.36849/JDD.6383
Moreno MA, Goniu N, Moreno PS, Diekema D. Ethics of social media research: common concerns and practical considerations. Cyberpsychol Behav Soc Netw. 2013; 16:708-13. DOI: https://doi.org/10.1089/cyber.2012.0334
Molino AC, Fleischer AB, Feldman SR. Patient Demographics and Utilization of Health Care Services for Molluscum Contagiosum. Pediatric Dermatology. 2004; 21:628-32. DOI: https://doi.org/10.1111/j.0736-8046.2004.21602.x
Chapa PJ, Mavura DR, Philemon R, Kini L, Masenga EJ. Contributing Factors and Outcome after Cryotherapy of Molluscum Contagiosum among Patients Attending Tertiary Hospital, Northern Tanzania: A Descriptive Prospective Cohort Study. Dermatol Res Pract. 2021; 2021:9653651. DOI: https://doi.org/10.1155/2021/9653651
Hanna D, Hatami A, Powell J, Marcoux D, Maari C, Savard P, Thibeault H, McCuaig C. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children. Pediatric Dermatology. 2006; 23:574-9. DOI: https://doi.org/10.1111/j.1525-1470.2006.00313.x
Badri T, Gandhi GR: Molluscum Contagiosum. In: StatPearls. edn. Treasure Island (FL): StatPearls Publishing; 2022.
Cathcart S, Coloe J, Morrell DS. Parental satisfaction, efficacy, and adverse events in 54 patients treated with cantharidin for molluscum contagiosum infection. Clin Pediatr (Phila). 2009; 48:161-5. DOI: https://doi.org/10.1177/0009922808326085
Harel A, Kutz AM, Hadj-Rabia S, Mashiah J. To Treat Molluscum Contagiosum or Not-Curettage: An Effective, Well-Accepted Treatment Modality. Pediatric Dermatology. 2016; 33:640-5. DOI: https://doi.org/10.1111/pde.12968
Guzman AK, Schairer DO, Garelik JL, Cohen SR. Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial. International Journal of Dermatology. 2018; 57:1001-6. DOI: https://doi.org/10.1111/ijd.14079
Syed TA, Lundin S, Ahmad M. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled, double-blind study. Dermatology. 1994; 189:65-8. DOI: https://doi.org/10.1159/000246787
Theos AU, Cummins R, Silverberg NB, Paller AS. Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial. Cutis. 2004; 74:134-8, 41-42.
Osio A, Deslandes E, Saada V, Morel P, Guibal F. Clinical characteristics of molluscum contagiosum in children in a private dermatology practice in the greater Paris area, France: a prospective study in 661 patients. Dermatology. 2011; 222:314-20. DOI: https://doi.org/10.1159/000327888
Netchiporouk E, Cohen BA. Recognizing and managing eczematous id reactions to molluscum contagiosum virus in children. Pediatrics. 2012; 129:e1072-5. DOI: https://doi.org/10.1542/peds.2011-1054
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
